Search filters

List of works by Katie Doores

2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies

scientific article published on 5 December 2012

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

scientific article

A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus

scientific article published on 01 December 2018

A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity

scientific article

A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex

scientific article published on 25 November 2019

Analysis of the dispersity in carbohydrate loading of synthetic glycoproteins using MALDI-TOF mass spectrometry.

scientific article

Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged

scientific article

Atomic-scale detection of organic molecules coupled to single-walled carbon nanotubes

scientific article published on 16 August 2007

B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates

scientific article published on 12 August 2013

Broad neutralization coverage of HIV by multiple highly potent antibodies

scientific article (publication date: 22 September 2011)

Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans

scientific article

Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers

scientific article published on 24 April 2014

Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope

scientific article

Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

scientific article published on 24 September 2020

Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies

scientific article published on 22 March 2022

Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization

scientific article published on 19 June 2017

Correction for Doores et al., Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope

scientific article published on June 2015

Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds

scientific article

Determination of N-linked Glycosylation in Viral Glycoproteins by Negative Ion Mass Spectrometry and Ion Mobility

scientific article published on January 2015

Direct deprotected glycosyl–asparagine ligation

scientific article published in 2006

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology.

scientific article published on 13 September 2012

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.

scientific article

Exploring and exploiting the therapeutic potential of glycoconjugates

scientific article

Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.

scholarly article

Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance

scientific article published on 15 April 2015

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies

scientific article

HIV Glycomics and Glycoproteomics

scientific article published on 8 October 2013

HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.

scientific article

Harnessing post-translational modifications for next-generation HIV immunogens

article

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies

scientific article published on 12 August 2015

Ligand amplification in a dynamic combinatorial glycopeptide library

scientific article published on 9 August 2005

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

scientific article published on 26 October 2020

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies

scientific article published on 2 February 2016

P04-05. Requirements for antibody domain exchange explored through mutation of the germline 2G12 antibody

scientific article

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope

article

P12-06. A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity

article

P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12.

scientific article published on 22 October 2009

Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans

scientific article published on 24 February 2010

Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV.

scientific article published on May 2014

Protein and Glycan Mimicry in HIV Vaccine Design.

scientific article published on 24 April 2019

Reagent switchable stereoselective beta(1,2) mannoside mannosylation: OH-2 of mannose is a privileged acceptor

scientific article published on 2 June 2008

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

article

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.

scientific article published on 09 September 2016

Rewritable glycochips.

scientific article

SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care

scientific article published on 07 June 2021

Signature of Antibody Domain Exchange by Native Mass Spectrometry and Collision-Induced Unfolding

scientific article published in 2018

Site-Selective Traceless Staudinger Ligation for Glycoprotein Synthesis Reveals Scope and Limitations

scientific article published on 19 May 2011

Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers

scientific article published on 16 June 2015

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

scientific article

Targeting Glycans on Human Pathogens for Vaccine Design

scientific article published on 26 July 2018

Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design

scientific article

The HIV glycan shield as a target for broadly neutralizing antibodies

scientific article

The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans

scientific article published on 17 April 2017

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.

scientific article

Translational Research in the Time of COVID-19-Dissolving Boundaries

scientific article published on 30 September 2020

Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope

scientific article

Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16.

scientific article

Very few substitutions in a germ line antibody are required to initiate significant domain exchange.

scientific article

“Polar patch” proteases as glycopeptiligases

scientific article published in 2005